Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs worldwide. However, during the last 10 years, accumulating evidence of an increased cardiovascular risk associated with use of NSAIDs has emerged, and NSAIDs have been linked to several cardiovascular adverse events, such as myocardial infarction, heart failure, and stroke. Cardiac arrest is the ultimate and most dreaded adverse drug event. . . We aimed to assess the association between NSAID use and the risk of out-of-hospital cardiac arrest.
Methods
Altogether, 28 947 out-of-hospital cardiac arrest patients (OHCA) were identified from the Danish Cardiac Arrest Registry during 2001 through 2010. The Danish Cardiac Arrest Registry contains all out-ofhospital cardiac arrests in Denmark, where a resuscitation attempt has been initiated. Cases with obvious late signs of death are not included in the registry.
We identified exposure to NSAIDs from the Danish Prescription Registry classified as follows: non-selective NSAIDs (diclofenac, naproxen, ibuprofen), and the selective cyclooxygenase-2 (COX-2) inhibitors (rofecoxib, celecoxib), and others. All pharmacies in Denmark are required to register all redeemed prescriptions in the Danish Prescription Registry, which ensures completeness of the registry.
The association between NSAIDs and risk of cardiac arrest was analysed in case-time-control models. We identified exposure to NSAIDs up to 30 days before cardiac arrest and compared it with exposure to NSAIDs in a previous control period from 60 to 90 days before cardiac arrest in the same cardiac arrest patient. Thereby patients were used as their own controls in another time period, which eliminated confounding from characteristics that remain stable over time (e.g. chronic comorbidity). Additionally, we included a control group from the background population (matched with patients 1:4 for age and sex) to adjust for possible time-variant biases related to exposure.
Results
Within the 30-day case period, 3376 (11.7%) persons were treated with an NSAID. Ibuprofen was the most commonly prescribed NSAID followed by diclofenac comprising 51.0 and 21.8% of total NSAIDs, respectively. Compared with non-users, NSAID users were more often women, had generally less cardiovascular diseases, such as ischaemic heart disease, myocardial infarction and heart failure, but were more likely to have cancer and rheumatic diseases (P < 0.05).
Use of non-selective NSAIDs was associated with a significantly increased risk of cardiac arrest, odds ratio (OR) 1.32 [95% confidence interval (95% CI) 1.18-1.48], whereas no significant risk was associated with use of the COX-2 selective inhibitors, OR 1.19 (95% CI 0.89-1.59), Figure 1 . The increased risk associated with use of nonselective NSAIDs was driven by an increased risk of OHCA associated with use of diclofenac, OR 1.50 (95% CI 1.23-1.82) and ibuprofen, OR 1.31 (95% CI 1.14-1.51), Figure 2 . Naproxen use was not significantly associated with cardiac arrest, and we did not find any significant associations between cardiac arrest and use of the COX-2 selective inhibitors, rofecoxib, and celecoxib.
The results were verified in several sensitivity analyses, such as excluding patients admitted within 60 days before cardiac arrest, excluding patients with cancer, and including only cardiac arrests of presumed cardiac causes. Figure 1 Risk of out-of-hospital cardiac arrest following treatment with non-steroidal anti-inflammatory drugs. Odds ratios derive from the conditional logistic regression analyses on case-time-control models. 'Events' comprises only persons with discordant exposure history, thus contributing to the analyses.
Conclusion
In this nationwide case-time control study we found that use of nonselective NSAIDs was associated with an increased risk of out-ofhospital cardiac arrest. The result was primarily driven by an increased risk of cardiac arrest in ibuprofen and diclofenac users. We found no significant association between cardiac arrest and use of the COX-2 selective inhibitors, rofecoxib and celecoxib, nor with the unselective NSAID naproxen. As few people in Denmark use rofecoxib, celecoxib, and naproxen, these results were marked by low statistical power.
To our knowledge, this is the first study to investigate the association between NSAIDs and out-of-hospital cardiac arrest. However, cardiac arrest is closely related to other cardiovascular morbidities, particularly ischaemic heart disease, and our findings of an increased cardiovascular risk associated with use of ibuprofen and diclofenac concurs with reporting from recent meta-analyses.
As many people, worldwide are using NSAIDs on a regular basis, the growing data on NAIDs cardiovascular adverse events strongly speak to the importance in making both health care personnel and the public at large more aware of the potential side effects to treatment with NSAIDs. Perseverance versus Pedigree Ankur Kalra, MD, a foreign medical graduate, discusses how determination and perseverance overcame 'pedigree' in his quest for a successful academic cardiology career in America. Determination was the ingredient to success. St Patrick's Day 2009 was particularly special for me. It was Match Day, and I had fulfilled a dream that I had been nurturing for several years: acceptance to a university-based internal medicine residency program in the USA. The dream began early in my residency in internal medicine at the All India Institute of Medical Sciences (AIIMS) in New Delhi, India's premier medical school and teaching hospital, when a senior colleague and friend mentored me to seek further postgraduate training in the USA. I was interested in becoming an interventional cardiologist, a yearning I had since high-school days. A postgraduate training berth in America would unlock several Figure 2 Risk of out-of-hospital cardiac arrest following treatment with the most common types of non-steroidal anti-inflammatory drugs. Odds ratios derive from the conditional logistic regression analyses on case-time-control models. 'Events' comprises only persons with discordant exposure history, thus contributing to the analyses.
